Bioceltix S.A. (WSE: BCX)
Health Care · Biotechnology · PL
zł69.60
-4.53% today · -23.6% 1Y
Bioceltix S.A. (WSE: BCX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $102.94M and employs 46 people.
Over the last twelve months the share price has lost 23.6%, trading between 70.00 and 102.40.
Tweenvest scores Bioceltix S.A. across four factors: quality 35/100, value 35/100. Its strongest factor is quality.
BCX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $102.94M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.49
- Dividend yield
- —
- Beta (5Y)
- 0.91
- 52-week high
- zł102.40
- 52-week low
- zł70.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.53M
- Employees
- 46
- Next earnings
- —
About Bioceltix S.A.
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
- ISIN
- PLBCLTX00019
- Founded
- 2016
- Listed since
- Nov 8, 2021
- Exchange
- Warsaw Stock Exchange
- Currency
- PLN
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Paradigm Biopharmaceuticals LimitedASX: PAR | $104.36M | AU$— | — |
| Corbus Pharmaceuticals Holdings, Inc.NasdaqCM: CRBP | $104.06M | $4.78 | -11.15% |
| Captor Therapeutics Spolka AkcyjnaWSE: CTX | $103.78M | zł60.00 | -6.25% |
| Shine-On BioMedical Co.,Ltd.TPEX: 6926 | $103.57M | NT$66.50 | -1.04% |
| Kintor Pharmaceutical LimitedSEHK: 9939 | $102.88M | HK$1.64 | -8.91% |
| ArcticZymes Technologies ASAOB: AZT | $102.18M | Nkr19.15 | -2.54% |
| Black Diamond Therapeutics, Inc.NasdaqGS: BDTX | $101.69M | $1.68 | -5.08% |
| TiumBio Co., Ltd.KOSDAQ: A321550 | $101.44M | ₩4,540.00 | +0.33% |
Figures last refreshed Oct 11, 2026.